AI assistant
Sending…
Moderna, Inc. — Director's Dealing 2020
Jul 2, 2020
30610_dirs_2020-07-02_a890c03e-3a0a-4131-824d-247dc19b953b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-07-01
Reporting Person: Tallett Elizabeth E (Director)
More from Moderna, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 23
Annual Report
2026
Feb 20
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13